Hospital
Mercy Hospital Berryville
Mercy Hospital Berryville was paid $2.86M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.
33Billing provider infoMERCY HOSPITAL BERRYVILLE
BERRYVILLE, AR 72616
BERRYVILLE, AR 72616
33aNPI1457306326assigned 05/22/2006
33bProvider typeCritical Access Hospital
28Total paid$2.86M
24GClaims108,383
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#5 of 34
Median peer was paid$773K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CLOUSE DAY, SHERRY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,182 | $349K | |
| 2019 | 17,079 | $409K | |
| 2020 | 12,510 | $290K | |
| 2021 | 14,390 | $347K | |
| 2022 | 16,227 | $551K | |
| 2023 | 18,930 | $541K | |
| 2024incomplete | 14,065 | $369K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 6,736 | 5,963 | $364K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 6,866 | 6,164 | $348K |
| 80053 | Comprehensive metabolic panel | 8.0% | 6,364 | 5,447 | $230K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 7.4% | 1,760 | 1,678 | $212K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.4% | 1,285 | 1,146 | $210K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 5,189 | 3,562 | $179K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.0% | 1,744 | 1,341 | $143K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 1,172 | 1,048 | $136K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 8,936 | 7,337 | $85K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.8% | 732 | 689 | $80K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 2,699 | 2,261 | $74K |
| 84484 | 2.6% | 2,732 | 2,247 | $73K |
83 more codes
| 36415 | Collection of venous blood by venipuncture | 2.2% | 5,175 | $64K |
| 71046 | Radiologic examination, chest; 2 views | 2.2% | 3,366 | $62K |
| 83880 | 1.8% | 1,846 | $52K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 1,122 | $43K |
| 83690 | 1.4% | 2,654 | $41K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 429 | $39K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 3,101 | $35K |
| 80305 | 1.2% | 2,003 | $35K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,526 | $29K |
| 87081 | <1% | 2,798 | $26K | |
| 83605 | <1% | 1,276 | $24K | |
| 81025 | <1% | 2,319 | $21K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,036 | $21K |
| 0240U | <1% | 174 | $18K | |
| 87631 | <1% | 208 | $16K | |
| 81001 | <1% | 3,451 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,555 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 610 | $13K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 1,359 | $13K |
| 82077 | <1% | 704 | $12K | |
| 81003 | <1% | 2,901 | $10K | |
| 87186 | <1% | 818 | $7K | |
| 83735 | <1% | 673 | $7K | |
| 87040 | <1% | 445 | $7K | |
| 87077 | <1% | 726 | $6K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 90 | $6K |
| 85610 | <1% | 925 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,399 | $5K |
| 80306 | <1% | 268 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 809 | $4K |
| 86140 | <1% | 582 | $4K | |
| 71020 | <1% | 268 | $4K | |
| 85379 | <1% | 250 | $3K | |
| 82962 | <1% | 346 | $3K | |
| 80076 | <1% | 105 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 289 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 63 | $3K |
| 85730 | <1% | 324 | $3K | |
| 82947 | <1% | 162 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 28 | $3K |
| 80050 | General health panel | <1% | 74 | $2K |
| 87634 | <1% | 30 | $2K | |
| 87147 | <1% | 193 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 59 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,014 | $2K |
| 72100 | <1% | 25 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 35 | $1K |
| 87070 | <1% | 93 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,940 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,497 | $1K |
| 87088 | <1% | 112 | $1K | |
| 74022 | <1% | 29 | $1K | |
| 97161 | <1% | 17 | $1K | |
| 82803 | <1% | 26 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 148 | $921.89 |
| 80320 | <1% | 82 | $863.63 | |
| 73630 | <1% | 39 | $853.42 | |
| 73610 | <1% | 27 | $848.72 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,536 | $716.30 |
| 87807 | <1% | 55 | $663.51 | |
| 80061 | Lipid panel | <1% | 86 | $549.80 |
| 73130 | <1% | 12 | $414.66 | |
| 87205 | <1% | 80 | $357.40 | |
| 73110 | <1% | 14 | $337.03 | |
| 80179 | <1% | 12 | $285.30 | |
| 80143 | <1% | 12 | $285.30 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 77 | $273.13 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 111 | $179.31 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 637 | $175.53 |
| 94761 | <1% | 54 | $140.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 410 | $127.28 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 349 | $99.40 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 247 | $95.12 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 51 | $75.80 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 69 | $70.09 |
| A9270 | Non-covered item or service | <1% | 463 | $68.54 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 111 | $29.61 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26 | $12.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 18 | $8.52 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 31 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 59 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLOUSE DAY, SHERRY (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospital Carthage | Carthage, MO | $18.78M |
| Mercy Hospital Aurora | Aurora, MO | $9.91M |
| Mercy Hospital Cassville | Cassville, MO | $9.56M |
| Mercy Hospital Logan County INC | Guthrie, OK | $5.02M |
| Mercy Hospital Healdton, INC. | Healdton, OK | $1.45M |
| Mercy Hospital Booneville | Booneville, AR | $1.31M |
| Mercy Hospital Watonga INC | Watonga, OK | $1.17M |
| Mercy Hospital Waldron | Waldron, AR | $1.17M |
| Mercy Hospital Perry | Perryville, MO | $1.05M |
| Mercy Hospital Logan County, INC | Guthrie, OK | $924K |
| Mercy Hospital Ozark | Ozark, AR | $839K |
| Mercy Hospital Paris | Paris, AR | $834K |
| Mercy Hospital Carthage | Carthage, MO | $788K |
| Mercy Hospital Kingfisher, INC | Kingfisher, OK | $385K |
| Mercy Hospital Paris | Paris, AR | $363K |
| Mercy Hospital Ozark | Ozark, AR | $268K |
| Mercy Hospital Booneville | Booneville, AR | $200K |
| Mercy Hospital Paris | Paris, AR | $152K |
| Mercy Hospital Waldron | Waldron, AR | $150K |
| Mercy Hospital Perry | Perryville, MO | $131K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.